CUE - Cue Biopharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5354.11M
Enterprise value 3329.77M
Trailing P/E N/A
Forward P/E 1-12.32
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)129.26
Price/book (mrq)13.10
Enterprise value/revenue 3120.37
Enterprise value/EBITDA 6-8.70

Trading information

Stock price history

Beta (5Y monthly) 1.64
52-week change 3202.16%
S&P500 52-week change 325.98%
52-week high 317.99
52-week low 34.69
50-day moving average 314.76
200-day moving average 39.79

Share statistics

Avg vol (3-month) 3229.7k
Avg vol (10-day) 3224.08k
Shares outstanding 522.99M
Float 16.05M
% held by insiders 117.95%
% held by institutions 131.31%
Shares short (30 Dec 2019) 4950.74k
Short ratio (30 Dec 2019) 42.84
Short % of float (30 Dec 2019) 45.03%
Short % of shares outstanding (30 Dec 2019) 44.13%
Shares short (prior month 28 Nov 2019) 4943.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Sep 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,413.37%

Management effectiveness

Return on assets (ttm)-53.90%
Return on equity (ttm)-118.64%

Income statement

Revenue (ttm)2.74M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)119.20%
Gross profit (ttm)-24.56M
EBITDA -37.91M
Net income avi to common (ttm)-39.4M
Diluted EPS (ttm)-1.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.38M
Total cash per share (mrq)1.37
Total debt (mrq)7.04M
Total debt/equity (mrq)26.07
Current ratio (mrq)3.17
Book value per share (mrq)1.18

Cash flow statement

Operating cash flow (ttm)-28.26M
Levered free cash flow (ttm)-12.78M